Clinical Trial Update: Obinutuzumab in Primary MN [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of obinutuzumab for primary membranous nephropathy is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• Obinutuzumab (obinutuzumab)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Membranous Nephropathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING